The science behind the story: Following a cancer vaccine from concept to proof of concept
The successful early-stage clinical trial of a personalized cancer vaccine for melanoma represents the culmination of almost a decade’s collaborative work to overcome challenges large and small.
The science behind the story: Following a cancer vaccine from concept to proof of concept
Source: Virology News